Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies

Head and Neck

Volumn 33, Issue 2, 2011, Pages 225-231

  Walvekar, Rohan R ^a,c   Filho, Pedro A Andrade ^a   Seethala, Raja R ^a   Gooding, William E ^b   Heron, Dwight E ^a   Johnson, Jonas T ^a   Ferris, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

malignant parotid tumors; neck dissection; neck metastasis; prognostic factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NECK METASTASIS; PAROTID GLAND CANCER; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MUCOEPIDERMOID; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, TEACHING; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PAROTID NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78751493141     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21433     Document Type: Article

References (24)

1. Barnes L, Eveson JW, Reichart P, Sidransky D,. WHO classification of tumours, vol. 9. Pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005.
2. Barnes L, Eveson J, Reichart P, Sidransky D,. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC; 2005.
3. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A,. Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol 2002; 122: 758-764.
4. Seifert G, Sobin LH,. The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer 1992; 70: 379-385.
5. Zbaren P, Schupbach J, Nuyens M, Stauffer E, Greiner R, Hausler R,. Carcinoma of the parotid gland. Am J Surg 2003; 186: 57-62.
6. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW,. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg 1989; 115: 316-321.
7. Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group. Head Neck 2004; 26: 681-693.
8. Spiro RH,. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8: 177-184.
9. Regis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, Flavia Logullo A, Magrin J,. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 2001; 127: 56-60.
10. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 2005; 133: 702-708.
11. Hosal AS, Fan C, Barnes L, Myers EN,. Salivary duct carcinoma. Otolaryngol Head Neck Surg 2003; 129: 720-725.
12. Stennert E, Kisner D, Jungehuelsing M, et al. High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 2003; 129: 720-723.
13. AJCC cancer staging manual. New York: Springer; 2002. pp 69-75.
14. Wahlberg P, Anderson H, Biorklund A, Moller T, Perfekt R,. Carcinoma of the parotid and submandibular glands-a study of survival in 2465 patients. Oral Oncol 2002; 38: 706-713.
15. Vander Poorten VL, Hart AA, van der Laan BF, et al. Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer 2003; 97: 1453-1463.
16. Takahama A Jr, Sanabria A, Benevides GM, de Almeida OP, Kowalski LP,. Comparison of two prognostic scores for patients with parotid carcinoma. Head Neck 2009; 31: 1188-1195.
17. Renehan AG, Gleave EN, Slevin NJ, McGurk M,. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer 1999; 80: 1296-1300.
18. Therkildsen MH, Christensen M, Andersen LJ, Schiodt T, Hansen HS,. Salivary gland carcinomas-prognostic factors. Acta Oncol 1998; 37: 701-713.
19. Medina JE,. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am 1998; 31: 815-822.
20. Klussmann JP, Ponert T, Mueller RP, Dienes HP, Guntinas-Lichius O,. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol 2008; 34: 932-937.
21. Zwerschke W, Jansen-Durr P,. Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 2000; 78: 1-29.
22. Vander Poorten VL, Balm AJ, Hilgers FJ, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer 1999; 85: 2057-2067.
23. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD,. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 1996; 77: 223-230.
24. Koka VN, Tiwari RM, van der Waal I, et al. Adenoid cystic carcinoma of the salivary glands: clinicopathological survey of 51 patients. J Laryngol Otol 1989; 103: 675-679.